Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac21f8139220f7063dbe42637479bfd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6cd85909d7a9206604a1ae9aaef1676 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56b43124ae579ec8f8ae9ef27e6b81c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5237b93f2efcef0943a92e64a6e8ba4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8109174d083ea18219e7659cb39a2749 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b3c73e2edb0b5b61fa3ad570eea758f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95bb9b7d62e79182163c3cb868358eac |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G21G4-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21G4-08 |
filingDate |
1999-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d3fa9dcce7a3d9ff01f02b5790e1c3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d46e6b07e833e12de1d93596d9189f69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb5a122d87f2bf82fc384e3300be273 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56f821161cd381194b674069e0b2c053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c6f5ad9d7e9164718ccb89789e50f34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_249de50a93bef07d687afda6d38378a7 |
publicationDate |
1999-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9967792-A1 |
titleOfInvention |
METHOD AND APPARATUS FOR PREPARING Bi-213 FOR HUMAN THERAPEUTIC USE |
abstract |
This invention relates to a method and an apparatus for preparing Bi-213 to be integrated in a radioimmunoconjugate for human therapeutic use. According to the invention the method comprises the sequence of steps as follows: a) an ampoule (5) containing colloid-free actinium-225, obtained from drying an actinium nitrate solution, is loaded into a container (20) provided with radiation panels (21); b) a dissolving medium is poured into the ampoule (5); c) the solution obtained in the ampoule is transferred into an ion exchange column (6); d) an elution medium is circulated through the column (6); e) the eluate containing eluted Bi-213 is pumped towards a vial (10) for quantification and quality control. |
priorityDate |
1998-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |